Home0NF0 • FRA
add
Mydecine Innovations Group Inc
Previous close
€0.0035
Day range
€0.0030 - €0.0030
Year range
€0.00050 - €0.076
Market cap
308.78K CAD
Avg Volume
330.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.63M | 85.17% |
Net income | -1.99M | -68.31% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.63M | -85.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.17K | 247.04% |
Total assets | 178.31K | -96.00% |
Total liabilities | 17.62M | 60.62% |
Total equity | -17.45M | — |
Shares outstanding | 61.76M | — |
Price to book | -0.01 | — |
Return on assets | -2,426.97% | — |
Return on capital | 40.42% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.99M | -68.31% |
Cash from operations | 46.57K | 301.43% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 46.57K | 301.43% |
Free cash flow | 388.85K | 111.06% |
About
Founded
2013
Headquarters
Website
Employees
3
